Literature DB >> 21995486

Hypothalamic-pituitary-adrenal axis suppression related to topical glucocorticoid therapy in a child with psoriatic exfoliative erythroderma.

Lauren S Campbell1, Michelle Chevalier, Richard A Levy, Arthur Rhodes.   

Abstract

Exfoliative erythroderma is a rare presentation of psoriasis in children and adults. We report a 9-year-old girl with exfoliative erythroderma secondary to plaque-type psoriasis who developed hypothalamic-pituitary-adrenal axis suppression resulting from topical treatment with a medium-potency glucocorticoid. This case emphasizes the need for awareness of this potentially life-threatening complication of topical glucocorticoid use, particularly in patients who have significant compromise of barrier function secondary to widespread skin disease.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21995486     DOI: 10.1111/j.1525-1470.2011.01471.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  Maximal Usage Trial: An Overview of the Design of Systemic Bioavailability Trial for Topical Dermatological Products.

Authors:  Edward Dennis Bashaw; Doanh C Tran; Chinmay G Shukla; Xiaomei Liu
Journal:  Ther Innov Regul Sci       Date:  2014-06-27       Impact factor: 1.778

2.  Psoriatic erythroderma and hypothalamus-pituitary axis suppression due to misuse of systemic steroid: two challenging cases.

Authors:  Gautam K Singh; Manas Chatterjee
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.